Skip to content
Search

Latest Stories

Boots pharmacists receive £750 pro rata bonus

Boots pharmacists receive £750 pro rata bonus

 The PDA secured a 5% pay award for Boots pharmacists during last year’s pay negotiations with the pharmacy chain

Pharmacists working at Boots have been awarded a non-consolidated £750 pro rata payment, following last year’s successful negotiations between the Pharmacists' Defence Association (PDA) Union and Boots UK.


Announcing this development, the PDA highlighted that the payment recognises the dedication of Boots pharmacists in delivering NHS core and advanced services, including the Pharmacy First Service, Common Ailments Service, Hypertension Case Finding and Pharmacy Contraception Service.

“This bonus is a recent example of the successful collaboration between the PDA and Boots, and how working alongside a trade union can benefit all parties involved,” the associated stated.

As the official union for pharmacists at Boots, the PDA plays a crucial role in negotiating their pay, terms, and conditions.

The PDA’s pay negotiations with the pharmacy chain last year led to a five percent pay increase for Boots pharmacists, which came into effect in November 2023.

The union revealed that discussions for the 2024 pay review are currently underway with Boots.

The PDA also has recognition agreements with other employers, including LloydsPharmacy Healthcare Services and all GP Federations in Northern Ireland.

These agreements enable formal negotiations on pay, terms, and conditions between employees and employers.

Pharmacists interested in establishing a recognition agreement at their workplace are encouraged to contact the PDA Member Support Centre for assistance.

Last month, Boots announced that it would proceed with closing the remaining stores as part of its plan to shut 300 UK pharmacy branches by the summer of 2024.

Last month, Boots confirmed to The Pharmaceutical Journal that it would complete the closure of the remaining stores of its planned programme to shut 300 UK pharmacy branches in the summer of 2024.

In June 2023, Walgreens Boots Alliance, Boots' parent company, announced its decision to close 300 UK pharmacies within a year as part of plans to save US$800m.

Currently, Boots UK operates 2,100 stores across the UK.

In its quarterly financial report released on 27 June 2024, Walgreens Boots Alliance said that part of its cost-cutting measure involved the closure of "up to 650 Boots stores" in the UK. By 31 May 2024, the company had closed 581 of these stores.

More For You

US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less